Company Filing History:
4 out of 66 
4 out of 117 
Years Active: 2016-2019
Title: François Romagne: Innovator in Immunology
Introduction
François Romagne is an accomplished inventor based in La Ciotat, France. He has made significant contributions to the field of immunology, particularly in the development of therapeutic strategies for treating immune disorders. Although he currently holds no granted patents, his work is noteworthy for its potential impact on medical science.
Latest Patent Applications
François Romagne's latest patent applications include:
1. **Monoclonal Antibodies Against NKG2A** - This invention relates to methods of treating immune disorders, particularly autoimmune or inflammatory disorders. It involves the use of antibodies or other compounds that prevent the stimulation of NKG2A receptors on NK cells, leading to the lysis of dendritic cells that contribute to the pathology of these disorders.
2. **Transgenic Animals and Methods of Making Recombinant Antibodies** - This invention describes a means for obtaining cells that produce human, humanized, or chimeric antibodies in commercially useful quantities. It allows for the selection and isolation of high antibody producer cells from animals for use in culture to produce antibodies. The invention also provides methods for the affinity maturation of human, humanized, or chimeric immunoglobulins.
Conclusion
François Romagne's innovative work in immunology showcases his dedication to advancing medical science, despite not having any granted patents at this time. His latest patent applications reflect a commitment to developing effective treatments for immune disorders.